PL3469372T3 - Sposoby diagnozowania i monitorowania z wykorzystaniem białek moczu jako markerów nefropatii IgA - Google Patents

Sposoby diagnozowania i monitorowania z wykorzystaniem białek moczu jako markerów nefropatii IgA

Info

Publication number
PL3469372T3
PL3469372T3 PL17736762.0T PL17736762T PL3469372T3 PL 3469372 T3 PL3469372 T3 PL 3469372T3 PL 17736762 T PL17736762 T PL 17736762T PL 3469372 T3 PL3469372 T3 PL 3469372T3
Authority
PL
Poland
Prior art keywords
markers
diagnosis
monitoring
methods
iga nephropathy
Prior art date
Application number
PL17736762.0T
Other languages
English (en)
Inventor
Krzysztof MUCHA
Leszek PĄCZEK
Radosław Zagożdżon
Bartosz FORONCEWICZ
Michał DADLEZ
Magdalena BAKUN
Jan PIWOWARSKI
Tomas PILZYS
Michał MARCINKOWSKI
Damian GARBICZ
Elżbieta GRZESIUK
Michał Florczak
Original Assignee
Warszawski Uniwersytet Medyczny
Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawski Uniwersytet Medyczny, Instytut Biochemii I Biofizyki Polskiej Akademii Nauk filed Critical Warszawski Uniwersytet Medyczny
Publication of PL3469372T3 publication Critical patent/PL3469372T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827Total protein determination, e.g. albumin in urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/493Physical analysis of biological material of liquid biological material urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/473Recognins, e.g. malignin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/79Transferrins, e.g. lactoferrins, ovotransferrins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
PL17736762.0T 2016-06-10 2017-06-12 Sposoby diagnozowania i monitorowania z wykorzystaniem białek moczu jako markerów nefropatii IgA PL3469372T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL41751516 2016-06-10
PCT/IB2017/053479 WO2017212463A1 (en) 2016-06-10 2017-06-12 Methods for diagnosis, differentiation and monitoring using urine proteins as markers in iga nephropathy

Publications (1)

Publication Number Publication Date
PL3469372T3 true PL3469372T3 (pl) 2023-12-04

Family

ID=59295240

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17736762.0T PL3469372T3 (pl) 2016-06-10 2017-06-12 Sposoby diagnozowania i monitorowania z wykorzystaniem białek moczu jako markerów nefropatii IgA

Country Status (6)

Country Link
US (1) US11029314B2 (pl)
EP (1) EP3469372B1 (pl)
DK (1) DK3469372T3 (pl)
ES (1) ES2946541T3 (pl)
PL (1) PL3469372T3 (pl)
WO (1) WO2017212463A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7457367B2 (ja) * 2019-01-17 2024-03-28 国立大学法人 岡山大学 IgA腎症の発症の可能性の判定方法およびキット
CA3173639A1 (en) 2020-01-31 2021-08-05 Krzysztof MUCHA Method of screening for a chronic kidney disease or glomerulopathy, method of monitoring a response to treatment of a chronic kidney disease or glomerulopathy in a subject and a method of treatment of a chronic kidney disease or glomerulopath
AU2020425858A1 (en) 2020-01-31 2022-12-15 Instytut Biochemii I Biofizyki Pan Method of differentiating of a chronic kidney disease or glomerulopathy, method of monitoring a response to treatment of a chronic kidney disease or glomerulopathy in a subject and a method of treatment of a chronic kidney disease or glomerulopathy

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003588A1 (en) 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
WO2008134526A2 (en) 2007-04-27 2008-11-06 University Of Florida Research Foundation Inc. Glycoprotein profiling of bladder cancer
EP2153234A2 (en) * 2007-05-11 2010-02-17 The Institutes for Pharmaceutical Discovery, LLC Methods for early diagnosis of kidney disease
KR100928403B1 (ko) 2008-10-01 2009-11-26 경북대학교 산학협력단 티지비엠 신증의 진단용 조성물 및 키트
US20100209948A1 (en) * 2009-01-28 2010-08-19 Industrial Technology Research Institute(ITRI) Biomarkers associated with nephropathy
KR100930025B1 (ko) * 2009-07-06 2009-12-07 경북대학교 산학협력단 이뮤노글로블린 에이 신증의 진단용 조성물 및 키트
US20120190044A1 (en) 2009-09-21 2012-07-26 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102590491B (zh) 2012-02-06 2014-12-10 中国人民解放军第三军医大学第一附属医院 一种用于早期筛查或辅助诊断泌尿系统疾病的检测试剂盒、检测方法及其用途
WO2013152989A2 (en) 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
US20150141273A1 (en) * 2012-04-26 2015-05-21 Stichting Vu-Vumc Biomarkers
US20140038203A1 (en) 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
KR101361038B1 (ko) 2013-02-21 2014-02-12 경북대학교 산학협력단 신장 이식 후 환자의 뇨 시료로부터 사구체여과율을 예측하는 방법
JP2016188761A (ja) * 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
US10078089B2 (en) 2014-08-29 2018-09-18 Children's Hospital Medical Center Compositions and methods for treating steroid resistant nephrotic syndrome and/or steroid sensitive nephrotic syndrome
US10590425B2 (en) * 2015-06-29 2020-03-17 Caris Science, Inc. Therapeutic oligonucleotides
PL236671B1 (pl) 2015-12-02 2021-02-08 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Sposób analizy białek w próbce moczu

Also Published As

Publication number Publication date
DK3469372T3 (da) 2023-06-06
WO2017212463A1 (en) 2017-12-14
ES2946541T3 (es) 2023-07-20
EP3469372B1 (en) 2023-03-08
EP3469372A1 (en) 2019-04-17
US20190339284A1 (en) 2019-11-07
US11029314B2 (en) 2021-06-08

Similar Documents

Publication Publication Date Title
IL266382A (en) Methods for assessing risk using a general and specific cell without DNA
EP3496859C0 (en) DETECTION PROBE AND METHOD OF USE THEREOF
ZA201605154B (en) Insecticidal proteins and methods for their use
IL248299A0 (en) A method and kit for determining the cellular or tissue origin of DNA
ZA201601430B (en) Insecticidal proteins and methods for their use
ZA201509369B (en) Insecticidal proteins and methods for their use
ZA201702161B (en) Insecticidal proteins and methods for their use
EP3229668A4 (en) Device, system and methods for assessing tissue structures, pathology, and healing
ZA201505705B (en) Phi-4 polypeptides and methods for their use
GB201509062D0 (en) OX40L fusion proteins and uses thereof
HK1215999A1 (zh) 改進的小葉和瓣膜裝置
EP3117653A4 (en) Device and method for modifying cell measurements based on device mobility
DK3539469T3 (da) System og fremgangsmåde til overvågning af bækkenbundsmusklerne
EP3204593A4 (en) Device and system for use in monitoring coring operations
IL246658A0 (en) Systems and methods for sleep diagnosis
IL259095A (en) A device for isolating cell segments from human and animal tissues and a method for using it
EP3399912A4 (en) SYSTEM AND METHOD FOR EVALUATING SLEEP STATUS
IL252118A0 (en) Analytical methods and arrays for their use
IL262670A (en) System and method for use in tissue monitoring and analysis
IL251158A0 (en) Biosensors for monitoring the location and movement of biological molecules in cells
GB201410226D0 (en) Methods and arrays for use in the same
PL3469372T3 (pl) Sposoby diagnozowania i monitorowania z wykorzystaniem białek moczu jako markerów nefropatii IgA
EP3557249A4 (en) URINE TESTING DEVICE AND URINE TESTING PROCEDURE
EP3199637A4 (en) Electrochemical measuring method and electrochemical measuring device
GB201411615D0 (en) Device and method for cell nuclei preparation